|
Johnson Matthey introduces X-Zyme enzymes
With the recent acquisition of X-Zyme GmbH, a leading biocatalysis company, Johnson Matthey Catalysts is excited to offer a novel family of bio-catalysts which complement the chiral synthetic capabilities of our current chemo-catalyst technology offering.
This combined portfolio of catalytic technologies allows us to design the most efficient synthetic route for our clients.
You now have one reliable resource for all your chemo- and bio- catalysis needs.
View our biocatalytic products and services.
|
